Albireo Pharma Inc is biopharmaceutical company. It is engaged in developing & commercializing novel bile acid modulators to treat orphan pediatric liver diseases & gastrointestinal disorders.

Albireo Pharma Inc

Albireo Pharma, Inc. is a pharmaceutical company engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions. The company was founded by Jan Mattsson on December 8, 2003 and is headquartered in Boston, MA.

Should you buy, sell, or hold Albireo Pharma Inc (ALBO) ?

Albireo Pharma Inc (ALBO) : Buy or Sell